Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Prognostic factors in early-stage leiomyosarcoma of the uterusManuela Pelmus, Frédérique Penault-Llorca, Louis Guillou, et al.
European Radiology|October 14, 2021
Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centrePierre-Antoine Linck, Cassandre Garnier, Marie-Pierre Depetiteville, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 18, 2011
Nucleic acid quality preservation by an alcohol-based fixative: comparison with frozen tumors in a routine pathology settingIsabelle Hostein, Nathalie Stock, Isabelle Soubeyran, et al.
Genes, Chromosomes & Cancer|July 11, 2017
Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle studyVirginie Bubien, Françoise Bonnet, Jennifer Dupiot-Chiron, et al.
Springerplus|September 26, 2015
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteriaIsabelle de Mascarel, Marc Debled, Véronique Brouste, et al.
Plos One|July 7, 2012
MED12 alterations in both human benign and malignant uterine soft tissue tumorsGaëlle Pérot, Sabrina Croce, Agnès Ribeiro, et al.
The Oncologist|July 4, 2013
Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancersMartine Boisserie-Lacroix, Gaëtan Macgrogan, Marc Debled, et al.
Biomedical Optics Express|July 10, 2018
Pilot study of freshly excised breast tissue response in the 300-600 GHz rangeQuentin Cassar, Amel Al-Ibadi, Laven Mavarani, et al.
Annales De Pathologie|April 20, 2004
[Diagnostic approach to breast papillary lesions]Gaëtan Macgrogan, Isabelle de Mascarel, Isabelle Soubeyran, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2015
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitudeMarc Debled, Gaëtan MacGrogan, Christelle Breton-Callu, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Prognostic factors in early-stage leiomyosarcoma of the uterusManuela Pelmus, Frédérique Penault-Llorca, Louis Guillou, et al.
European Radiology|October 14, 2021
Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centrePierre-Antoine Linck, Cassandre Garnier, Marie-Pierre Depetiteville, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 18, 2011
Nucleic acid quality preservation by an alcohol-based fixative: comparison with frozen tumors in a routine pathology settingIsabelle Hostein, Nathalie Stock, Isabelle Soubeyran, et al.
Genes, Chromosomes & Cancer|July 11, 2017
Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle studyVirginie Bubien, Françoise Bonnet, Jennifer Dupiot-Chiron, et al.
Springerplus|September 26, 2015
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteriaIsabelle de Mascarel, Marc Debled, Véronique Brouste, et al.
Plos One|July 7, 2012
MED12 alterations in both human benign and malignant uterine soft tissue tumorsGaëlle Pérot, Sabrina Croce, Agnès Ribeiro, et al.
The Oncologist|July 4, 2013
Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancersMartine Boisserie-Lacroix, Gaëtan Macgrogan, Marc Debled, et al.
Biomedical Optics Express|July 10, 2018
Pilot study of freshly excised breast tissue response in the 300-600 GHz rangeQuentin Cassar, Amel Al-Ibadi, Laven Mavarani, et al.
Annales De Pathologie|April 20, 2004
[Diagnostic approach to breast papillary lesions]Gaëtan Macgrogan, Isabelle de Mascarel, Isabelle Soubeyran, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2015
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitudeMarc Debled, Gaëtan MacGrogan, Christelle Breton-Callu, et al.
Pageof 8